Our City Online


MyCannX Looks to Form Medical Cannabis Network Built on Outreach, Education

Lauren Sega Lauren Sega MyCannX Looks to Form Medical Cannabis Network Built on Outreach, EducationPhoto by Katheirne Hitt.
Decrease Font Size Increase Font Size Text Size Print This Page

MyCannX, a Maryland-based company focused on community outreach and education around medical marijuana, is making the move to Ohio.

MyCannX founder & CEO Shawnta Hopkins-Greene.

As the state nears its September 8 deadline to make the drug available to patients, MyCannX — currently operating in Maryland and Washington D.C. — is beginning to establish its Ohio network of potential patients, physicians and dispensaries. Headed by Columbus native Shawnta Hopkins-Greene, the company will take up residence in German Village next week.

Hopkins-Greene, 45, happened into the medical marijuana field in the midst of research on the drug. She’d heard already that marijuana could be used effectively as a treatment for Autism and was looking further into it as a possibility for her 12-year-old son Marcus Tyler, who was diagnosed with Autism at age 5.

During this period of exploration, Hopkins-Greene was solicited as an investor in the burgeoning medical marijuana industry in Maryland. Already an entrepreneur buying and selling precious metals at home parties, she took her business savvy and launched MyCannX in 2013, the year Maryland legalized marijuana for medical use.

MyCannX’s purpose: create a network that connects prospective patients to qualified physicians and dispensaries that put education first — “places that have medical directors, a medical focus,” Hopkins-Greene says.

The company partners with clinics, hospitals, nursing homes, and senior living centers to conduct face-to-face (and free) community outreach with patients and caregivers.

“One of the things we’re focusing on is veteran and children’s education,” she continues. “We go out and provide free training about the laws in the state, the different uses [of the drug], consumption methods — anything related to medical cannabis.”

They also educate physicians on the concept of strain alignment, or knowing which strain of marijuana should be used to treat any given ailment.

“Cancer, for example. There’s an oil out there that’s high in THC and CBD that’s proven to shrink cancer cells,” she says. “Or for seizures, there’s a strain called Charlotte’s Web, which is low in THC and high in CBD, and CBD doesn’t give you that head high feeling.”

In their outreach, MyCannX shows individuals how to enroll in Ohio’s medical marijuana program, connects interested patients to physicians that can prescribe the drug, and directs them to dispensaries that have medically trained personnel on-site for assistance. If a dispensary lacks such expertise, MyCannX will train the staff.

At the core of the company is the goal to destigmatize the drug and build up a trusting and informed patient base. Contracting with dispensaries with either a medical focus or sufficient training from MyCannX, the company is able to provide the free community outreach and education that will lead to a booming medical cannabis market.

To start, MyCannX will partner with Ohio dispensaries that also have operations in Maryland, which include Grassroots and Greenleaf, both in northeast Ohio.

While the State of Ohio admitted that it likely would not meet the September 8 deadline to have medical cannabis on the shelves for needy patients, MyCannX will establish their Columbus headquarters next week in German Village.

For more information, visit mycannx.com.

Print Friendly, PDF & Email


business categories

    Subscribe below: